List of Tables
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Rheumatology Drugs Assessment
Table 9. COVID-19 Impact: Rheumatology Drugs Market Trends
Table 10. COVID-19 Impact Global Rheumatology Drugs Market Size
Table 11. Global Rheumatology Drugs Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Rheumatology Drugs Market Growth Drivers
Table 14. Global Rheumatology Drugs Market Restraints
Table 15. Global Rheumatology Drugs Market Opportunities
Table 16. Global Rheumatology Drugs Market Challenges
Table 17. By Players, Rheumatology Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Rheumatology Drugs Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Rheumatology Drugs Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Rheumatology Drugs Market
Table 21. Key Players Rheumatology Drugs Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Rheumatology Drugs Market Size 2019-2021, (US$ Million)
Table 24. Global Rheumatology Drugs Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Rheumatology Drugs Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Rheumatology Drugs Market Size, 2019-2021 (US$ Million)
Table 57. Takeda Pharmaceutical Business Overview
Table 58. Takeda Pharmaceutical Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Takeda Pharmaceutical Rheumatology Drugs Product
Table 60. Takeda Pharmaceutical Response to COVID-19 and Related Developments
Table 61. Sanofi Business Overview
Table 62. Sanofi Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Sanofi Rheumatology Drugs Product
Table 64. Sanofi Response to COVID-19 and Related Developments
Table 65. Genentech Business Overview
Table 66. Genentech Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Genentech Rheumatology Drugs Product
Table 68. Genentech Response to COVID-19 and Related Developments
Table 69. Novartis Business Overview
Table 70. Novartis Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Novartis Rheumatology Drugs Product
Table 72. Novartis Response to COVID-19 and Related Developments
Table 73. Janssen Biotech Business Overview
Table 74. Janssen Biotech Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Janssen Biotech Rheumatology Drugs Product
Table 76. Janssen Biotech Response to COVID-19 and Related Developments
Table 77. Amgen Business Overview
Table 78. Amgen Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Amgen Rheumatology Drugs Product
Table 80. Amgen Response to COVID-19 and Related Developments
Table 81. AbbVie Business Overview
Table 82. AbbVie Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. AbbVie Rheumatology Drugs Product
Table 84. AbbVie Response to COVID-19 and Related Developments
Table 85. Pfizer Business Overview
Table 86. Pfizer Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pfizer Rheumatology Drugs Product
Table 88. Pfizer Response to COVID-19 and Related Developments
Table 89. Bristol-Myers Squibb Company Business Overview
Table 90. Bristol-Myers Squibb Company Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Bristol-Myers Squibb Company Rheumatology Drugs Product
Table 92. Bristol-Myers Squibb Company Response to COVID-19 and Related Developments
Table 93. Merck & Co. Business Overview
Table 94. Merck & Co. Rheumatology Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Merck & Co. Rheumatology Drugs Product
Table 96. Merck & Co. Response to COVID-19 and Related Developments
List of Figures
Figure 1. Rheumatology Drugs Product Picture
Figure 2. Rheumatology Drugs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Rheumatology Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Rheumatology Drugs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Rheumatology Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Rheumatology Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Rheumatology Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Rheumatology Drugs Market Size Market Share, 2019-2021
